digital health M&A
BioTelemetry will pay $45 million in upfront cash with additional performance-based earn-out considerations of no less than $20 million.
ClassPass will shut down GuavaPass' service in markets where the two companies were competing, and maintain the latter company's other operations under the ClassPass name "until further notice."
As part of the deal Tabula Rasa will acquire the DoseMeRx platform, which gives clinicians information about how a patient will metabolize and absorb certain medications.
ResMed is expected to close the $225M deal to purchase the smart inhaler company by March 2019.
The acquisition will allow Medtronic to integrate Nutrino's predictive glycemic response algorithm into its technology.
MindMaze said that it plans to continue development of NMI's gamified therapy for cognitive and motor capability impairment.
The resulting integrated platform will be known as “GetWell Loop,” and will include support for care pathways, remote patient monitoring, virtual check-ins and other capabilities.
The acquisition is expected to help ResMed expand its SaaS offerings in the long-term care setting.
The collective entity offers its vertically-integrated service to patients in Northern California, and is eyeing platform partnerships elsewhere in the country.
The machine learning and women's cyclical health company said that it made the purchase to prepare for next year's launch of the Priya Personal Fertility Sensor platform.